Please see below a list of Prof Schilling’s most recent medical publications relating to our work in AF.

 

  1. A novel technique for performing transseptal puncture guided by a non-fluoroscopic 3D mapping system.

    Sawhney, V, Breitenstein, A, Watts, T, Garcia, J, Finlay, M, Lowe, M et al..

    Pacing Clin Electrophysiol. 2018; :.

    PubMed PMID:30397922.

    doi: 10.1111/pace.13541.
  2. Atrial fibrillation in acute coronary syndromes: Could white blood cell count be the link?.

    Papageorgiou, N, Lim, WY, Schilling, RJ.

    Int. J. Cardiol. 2018; :.

    PubMed PMID:30266351.

    doi: 10.1016/j.ijcard.2018.09.062.
  3. Automated detection of repetitive focal activations in persistent atrial fibrillation: Validation of a novel detection algorithm and application through panoramic and sequential mapping.

    Honarbakhsh, S, Schilling, RJ, Providencia, R, Keating, E, Sporton, S, Lowe, M et al..

    J. Cardiovasc. Electrophysiol. 2018; :.

    PubMed PMID:30255666.

    doi: 10.1111/jce.13752.
  4. Anticoagulation and the risk of complications in ventricular tachycardia and premature ventricular complex ablation.

    Lane, JD, Cannie, D, Volkova, E, Graham, A, Chow, A, Earley, MJ et al..

    Pacing Clin Electrophysiol. 2018;41 (11):1454-1460.

    PubMed PMID:30221382.

    doi: 10.1111/pace.13502.
  5. Subcutaneous implantable defibrillator in dextrocardia secondary to Lobectomy.

    Monkhouse, C, Koutsogeorgis, I, Schilling, R, Lambiase, PD.

    Clin Case Rep. 2018;6 (9):1727-1729.

    PubMed PMID:30214751. PubMed Central PMC6132161.

    doi: 10.1002/ccr3.1474.
  6. Ventricular tachycardia ablation in structural heart disease: Impact of ablation strategy and non-inducibility as an end-point on long term outcome.

    Breitenstein, A, Sawhney, V, Providencia, R, Honarbakhsh, S, Ullah, W, Dhinoja, MB et al..

    Int. J. Cardiol. 2018; :.

    PubMed PMID:30196998.

    doi: 10.1016/j.ijcard.2018.08.099.
  7. Through-needle all-optical ultrasound imaging in vivo: a preclinical swine study.

    Finlay, MC, Mosse, CA, Colchester, RJ, Noimark, S, Zhang, EZ, Ourselin, S et al..

    Light Sci Appl. 2017;6 (12):e17103.

    PubMed PMID:30167220. PubMed Central PMC6062020.

    doi: 10.1038/lsa.2017.103.
  8. Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies.

    Lane, JD, Whittaker-Axon, S, Schilling, RJ, Lowe, MD.

    Indian Pacing Electrophysiol J. 2018; :.

    PubMed PMID:30145313.

    doi: 10.1016/j.ipej.2018.08.004.
  9. Comparison of a high throughput day case atrial fibrillation ablation service in a local hospital with standard regional tertiary cardiac centre care.

    Opel, A, Mansell, J, Butler, A, Schwartz, R, Fannon, M, Finlay, M et al..

    Europace. 2018; :.

    PubMed PMID:30085050.

    doi: 10.1093/europace/euy153.
  10. Structural remodeling and conduction velocity dynamics in the human left atrium: Relationship with reentrant mechanisms sustaining atrial fibrillation.

    Honarbakhsh, S, Schilling, RJ, Orini, M, Providencia, R, Keating, E, Finlay, M et al..

    Heart Rhythm. 2018; :.

    PubMed PMID:30026014.

    doi: 10.1016/j.hrthm.2018.07.019.
  11. Sudden Cardiac Death and Arrhythmias.

    Srinivasan, NT, Schilling, RJ.

    Arrhythm Electrophysiol Rev. 2018;7 (2):111-117.

    PubMed PMID:29967683. PubMed Central PMC6020177.

    doi: 10.15420/aer.2018:15:2.
  12. The effect of intracoronary sodium nitrite on the burden of ventricular arrhythmias following primary percutaneous coronary intervention for acute myocardial infarction.

    Jones, DA, Rathod, KS, Williamson, A, Harrington, D, Andiapen, M, van Eijl, S et al..

    Int. J. Cardiol. 2018;266 :1-6.

    PubMed PMID:29887423.

    doi: 10.1016/j.ijcard.2018.01.029.
  13. Thrombo-embolic events in left ventricular endocardial pacing: long-term outcomes from a multicentre UK registry.

    Sawhney, V, Domenichini, G, Gamble, J, Furniss, G, Panagopoulos, D, Lambiase, P et al..

    Europace. 2018; :.

    PubMed PMID:29868905.

    doi: 10.1093/europace/euy107.
  14. Catheter ablation for atrial fibrillation on uninterrupted direct oral anticoagulants: A safe approach.

    Sawhney, V, Shaukat, M, Volkova, E, Jones, N, Providencia, R, Honarbakhsh, S et al..

    Pacing Clin Electrophysiol. 2018; :.

    PubMed PMID:29768672.

    doi: 10.1111/pace.13370.
  15. Ablation Index and Surround Flow Catheter Irrigation: Impedance-Based Appraisal in Clinical Ablation.

    Ullah, W, Hunter, RJ, Finlay, MC, McLean, A, Dhinoja, MB, Sporton, S et al..

    JACC Clin Electrophysiol. 2017;3 (10):1080-1088.

    PubMed PMID:29759489.

    doi: 10.1016/j.jacep.2017.03.011.
  16. Characterization of drivers maintaining atrial fibrillation: Correlation with markers of rapidity and organization on spectral analysis.

    Honarbakhsh, S, Schilling, RJ, Providencia, R, Keating, E, Chow, A, Sporton, S et al..

    Heart Rhythm. 2018;15 (9):1296-1303.

    PubMed PMID:29753943.

    doi: 10.1016/j.hrthm.2018.04.020.
  17. Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP).

    Dan, GA, Martinez-Rubio, A, Agewall, S, Boriani, G, Borggrefe, M, Gaita, F et al..

    Europace. 2018;20 (5):731-732an.

    PubMed PMID:29438514.

    doi: 10.1093/europace/eux373.
  18. A Novel Mapping System for Panoramic Mapping of the Left Atrium: Application to Detect and Characterize Localized Sources Maintaining Atrial Fibrillation.

    Honarbakhsh, S, Schilling, RJ, Dhillon, G, Ullah, W, Keating, E, Providencia, R et al..

    JACC Clin Electrophysiol. 2018;4 (1):124-134.

    PubMed PMID:29387810. PubMed Central PMC5777816.

    doi: 10.1016/j.jacep.2017.09.177.
  19. Association of genetic variation in telomere-related SNP and telomerase with ventricular arrhythmias in ischemic cardiomyopathy.

    Sawhney, V, Brouilette, S, Campbell, N, Coppen, S, Baker, V, Hunter, R et al..

    Pacing Clin Electrophysiol. 2018;41 (3):261-266.

    PubMed PMID:29344960.

    doi: 10.1111/pace.13284.
  20. Postmortem ICD interrogation in mode of death classification.

    Nikolaidou, T, Johnson, MJ, Ghosh, JM, Marincowitz, C, Shah, S, Lammiman, MJ et al..

    J. Cardiovasc. Electrophysiol. 2018;29 (4):573-583.

    PubMed PMID:29316018.

    doi: 10.1111/jce.13414.
  21. A Simplified Trans-Septal Puncture Technique using a Needle Free Approach for Cryoablation of Atrial Fibrillation.

    Honarbakhsh, S, O'Brien, B, Schilling, RJ.

    J Atr Fibrillation. ;10 (2):1628.

    PubMed PMID:29250235. PubMed Central PMC5673294.

    doi: 10.4022/jafib.1628.
  22. Diagnosis and Prognosis in Sudden Cardiac Arrest Survivors Without Coronary Artery Disease: Utility of a Clinical Approach Using Cardiac Magnetic Resonance Imaging.

    Rodrigues, P, Joshi, A, Williams, H, Westwood, M, Petersen, SE, Zemrak, F et al..

    Circ Cardiovasc Imaging. 2017;10 (12):e006709.

    PubMed PMID:29237609.

    doi: 10.1161/CIRCIMAGING.117.006709.
  23. Can Transesophageal Echocardiography Be Performed Safely Using a Laryngeal Mask Airway During Atrial Fibrillation Ablation?.

    Balmforth, D, Smith, A, Nagore, D, Schilling, R, O'Brien, B.

    J. Cardiothorac. Vasc. Anesth. 2018;32 (2):790-795.

    PubMed PMID:29229253.

    doi: 10.1053/j.jvca.2017.10.040.
  24. Fluoroscopy-free AF ablation using transesophageal echocardiography and electroanatomical mapping technology.

    O'Brien, B, Balmforth, DC, Hunter, RJ, Schilling, RJ.

    J Interv Card Electrophysiol. 2017;50 (3):235-244.

    PubMed PMID:29134434.

    doi: 10.1007/s10840-017-0288-9.
  25. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    J Arrhythm. 2017;33 (5):369-409.

    PubMed PMID:29021841. PubMed Central PMC5634725.

    doi: 10.1016/j.joa.2017.08.001.
  26. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    Europace. 2018;20 (1):157-208.

    PubMed PMID:29016841. PubMed Central PMC5892164.

    doi: 10.1093/europace/eux275.
  27. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    Europace. 2018;20 (1):e1-e160.

    PubMed PMID:29016840. PubMed Central PMC5834122.

    doi: 10.1093/europace/eux274.
  28. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.

    De Caterina, R, Brüggenjürgen, B, Darius, H, Köhler, S, Lucerna, M, Pecen, L et al..

    Arch Cardiovasc Dis. 2018;111 (2):74-84.

    PubMed PMID:28942115.

    doi: 10.1016/j.acvd.2017.04.007.
  29. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    J Interv Card Electrophysiol. 2017;50 (1):1-55.

    PubMed PMID:28914401. PubMed Central PMC5633646.

    doi: 10.1007/s10840-017-0277-z.
  30. Panoramic atrial mapping with basket catheters: A quantitative analysis to optimize practice, patient selection, and catheter choice.

    Honarbakhsh, S, Schilling, RJ, Providência, R, Dhillon, G, Sawhney, V, Martin, CA et al..

    J. Cardiovasc. Electrophysiol. 2017;28 (12):1423-1432.

    PubMed PMID:28862787.

    doi: 10.1111/jce.13331.
  31. Impact of an Age-Adjusted Co-morbidity Index on Survival of Patients With Heart Failure Implanted With Cardiac Resynchronization Therapy Devices.

    Ioannou, A, Papageorgiou, N, Barber, H, Falconer, D, Barra, S, Babu, G et al..

    Am. J. Cardiol. 2017;120 (7):1158-1165.

    PubMed PMID:28784235.

    doi: 10.1016/j.amjcard.2017.06.056.
  32. The Impact of Cryoballoon Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation on Healthcare Utilization and Costs: An Economic Analysis From the FIRE AND ICE Trial.

    Chun, KRJ, Brugada, J, Elvan, A, Gellér, L, Busch, M, Barrera, A et al..

    J Am Heart Assoc. 2017;6 (8):.

    PubMed PMID:28751544. PubMed Central PMC5586445.

    doi: 10.1161/JAHA.117.006043.
  33. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

    Calkins, H, Hindricks, G, Cappato, R, Kim, YH, Saad, EB, Aguinaga, L et al..

    Heart Rhythm. 2017;14 (10):e275-e444.

    PubMed PMID:28506916. PubMed Central PMC6019327.

    doi: 10.1016/j.hrthm.2017.05.012.
  34. Characterization and consistency of interactions of triggers and substrate at the onset of paroxysmal atrial fibrillation.

    Jones, DG, Markides, V, Chow, AWC, Schilling, RJ, Kanagaratnam, P, Wong, T et al..

    Europace. 2017;19 (9):1454-1462.

    PubMed PMID:28339601.

    doi: 10.1093/europace/euw229.
  35. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.

    Calkins, H, Willems, S, Gerstenfeld, EP, Verma, A, Schilling, R, Hohnloser, SH et al..

    N. Engl. J. Med. 2017;376 (17):1627-1636.

    PubMed PMID:28317415.

    doi: 10.1056/NEJMoa1701005.
  36. Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants.

    Allan, V, Honarbakhsh, S, Casas, JP, Wallace, J, Hunter, R, Schilling, R et al..

    Thromb. Haemost. 2017;117 (5):837-850.

    PubMed PMID:28229164. PubMed Central PMC5442605.

    doi: 10.1160/TH16-11-0825.
  37. Validation of a High-Fidelity Electrophysiology Simulator and Development of a Proficiency-Based Simulator Training Program.

    Ullah, W, Hunter, RJ, Finlay, M, Earley, MJ, McLean, A, Marazzi, R et al..

    Simul Healthc. 2017;12 (1):41-46.

    PubMed PMID:28146452.

    doi: 10.1097/SIH.0000000000000197.
  38. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.

    Frontera, A, Panniker, S, Breitenstein, A, Bruno, VD, Connolly, GM, Wilson, D et al..

    Europace. 2017;19 (8):1369-1377.

    PubMed PMID:27974359.

    doi: 10.1093/europace/euw236.
  39. Panoramic characterization of endocardial left atrial activation during human persistent AF: Insights from non-contact mapping.

    Lee, G, McLellan, AJ, Hunter, RJ, Lovell, MJ, Finlay, M, Ullah, W et al..

    Int. J. Cardiol. 2017;228 :406-411.

    PubMed PMID:27870970.

    doi: 10.1016/j.ijcard.2016.11.085.
  40. Adenosine-guided pulmonary vein isolation versus conventional pulmonary vein isolation in patients undergoing atrial fibrillation ablation: An updated meta-analysis.

    Papageorgiou, N, Providência, R, Srinivasan, N, Bronis, K, Costa, FM, Cavaco, D et al..

    Int. J. Cardiol. 2017;227 :151-160.

    PubMed PMID:27863291.

    doi: 10.1016/j.ijcard.2016.11.152.
  41. Medium-term outcomes of idiopathic ventricular fibrillation survivors and family screening: a multicentre experience.

    Honarbakhsh, S, Srinivasan, N, Kirkby, C, Firman, E, Tobin, L, Finlay, M et al..

    Europace. 2017;19 (11):1874-1880.

    PubMed PMID:27738067.

    doi: 10.1093/europace/euw251.
  42. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: results from the PREFER in AF registry.

    Bakhai, A, Darius, H, De Caterina, R, Smart, A, Le Heuzey, JY, Schilling, RJ et al..

    Eur Heart J Qual Care Clin Outcomes. 2016;2 (4):299-305.

    PubMed PMID:29474715.

    doi: 10.1093/ehjqcco/qcw031.
  43. A dolus of i.v. amiodarone.

    Finlay, MC, Specterman, M, Schilling, RJ.

    Eur. Heart J. 2017;38 (17):1336-1338.

    PubMed PMID:27469374.

    doi: 10.1093/eurheartj/ehw327.
  44. Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data.

    Ullah, W, McLean, A, Tayebjee, MH, Gupta, D, Ginks, MR, Haywood, GA et al..

    Heart Rhythm. 2016;13 (9):1761-7.

    PubMed PMID:27173976.

    doi: 10.1016/j.hrthm.2016.05.011.
  45. Endocardial biventricular defibrillator implantation in a patient with superior vena cava obstruction.

    Finlay, MC, Lall, K, Hunter, RJ, Schilling, RJ.

    Europace. 2016;18 (4):500.

    PubMed PMID:26917620. PubMed Central PMC4865057.

    doi: 10.1093/europace/euv052.
  46. Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.

    Ullah, W, Ling, LH, Prabhu, S, Lee, G, Kistler, P, Finlay, MC et al..

    Europace. 2016;18 (5):679-86.

    PubMed PMID:26843584.

    doi: 10.1093/europace/euv440.
  47. Point-by-Point Radiofrequency Ablation Versus the Cryoballoon or a Novel Combined Approach: A Randomized Trial Comparing 3 Methods of Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation (The Cryo Versus RF Trial).

    Hunter, RJ, Baker, V, Finlay, MC, Duncan, ER, Lovell, MJ, Tayebjee, MH et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (12):1307-14.

    PubMed PMID:26727045.

    doi: 10.1111/jce.12846.
  48. The Impact of Known Heart Disease on Long-Term Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Multicenter International Study.

    Prabhu, S, Ling, LH, Ullah, W, Hunter, RJ, Schilling, RJ, McLellan, AJ et al..

    J. Cardiovasc. Electrophysiol. 2016;27 (3):281-9.

    PubMed PMID:26707369.

    doi: 10.1111/jce.12899.
  49. The lung impedance monitoring in treatment of chronic heart failure (the LIMIT-CHF study).

    Domenichini, G, Rahneva, T, Diab, IG, Dhillon, OS, Campbell, NG, Finlay, MC et al..

    Europace. 2016;18 (3):428-35.

    PubMed PMID:26683599.

    doi: 10.1093/europace/euv293.
  50. Comorbidity of atrial fibrillation and heart failure.

    Ling, LH, Kistler, PM, Kalman, JM, Schilling, RJ, Hunter, RJ.

    Nat Rev Cardiol. 2016;13 (3):131-47.

    PubMed PMID:26658575.

    doi: 10.1038/nrcardio.2015.191.
  51. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study.

    Rodríguez-Mañero, M, Sacher, F, de Asmundis, C, Maury, P, Lambiase, PD, Sarkozy, A et al..

    Heart Rhythm. 2016;13 (3):669-82.

    PubMed PMID:26538325.

    doi: 10.1016/j.hrthm.2015.10.038.
  52. Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis.

    Anselmino, M, Matta, M, D'ascenzo, F, Pappone, C, Santinelli, V, Bunch, TJ et al..

    Europace. 2015;17 (10):1518-25.

    PubMed PMID:26498716.

    doi: 10.1093/europace/euv214.
  53. Use of a contact force-sensing ablation catheter with advanced catheter location significantly reduces fluoroscopy time and radiation dose in catheter ablation of atrial fibrillation.

    Lee, G, Hunter, RJ, Lovell, MJ, Finlay, M, Ullah, W, Baker, V et al..

    Europace. 2016;18 (2):211-8.

    PubMed PMID:26318548.

    doi: 10.1093/europace/euv186.
  54. The Hot and the Cold: Radiofrequency Versus Cryoballoon Ablation for Atrial Fibrillation.

    Ang, R, Domenichini, G, Finlay, MC, Schilling, RJ, Hunter, RJ.

    Curr Cardiol Rep. 2015;17 (9):631.

    PubMed PMID:26266757.

    doi: 10.1007/s11886-015-0631-7.
  55. Impact of Catheter Contact Force on Human Left Atrial Electrogram Characteristics in Sinus Rhythm and Atrial Fibrillation.

    Ullah, W, Hunter, RJ, Baker, V, Ling, LH, Dhinoja, MB, Sporton, S et al..

    Circ Arrhythm Electrophysiol. 2015;8 (5):1030-9.

    PubMed PMID:26152560.

    doi: 10.1161/CIRCEP.114.002483.
  56. Evolution of Electrocardiographic and Structural Features Over 3 Decades in Arrhythmogenic Cardiomyopathy.

    Abrams, DJ, Kirkby, C, Page, SP, Earley, MJ, Nitiou, D, Kelsell, DP et al..

    Circulation. 2015;131 (25):2233-5.

    PubMed PMID:26099957.

    doi: 10.1161/CIRCULATIONAHA.115.014371.
  57. Pulmonary vein measurements on pre-procedural CT/MR imaging can predict difficult pulmonary vein isolation and phrenic nerve injury during cryoballoon ablation for paroxysmal atrial fibrillation.

    Ang, R, Hunter, RJ, Baker, V, Richmond, L, Dhinoja, M, Sporton, S et al..

    Int. J. Cardiol. 2015;195 :253-8.

    PubMed PMID:26048388.

    doi: 10.1016/j.ijcard.2015.05.089.
  58. T-wave oversensing in patients with Brugada syndrome: true bipolar versus integrated bipolar implantable cardioverter defibrillator leads: multicenter retrospective study.

    Rodríguez-Mañero, M, de Asmundis, C, Sacher, F, Arbelo, E, Probst, V, Castro-Hevia, J et al..

    Circ Arrhythm Electrophysiol. 2015;8 (4):792-8.

    PubMed PMID:26041387.

    doi: 10.1161/CIRCEP.115.002871.
  59. Ambulatory respiratory rate trends identify patients at higher risk of worsening heart failure in implantable cardioverter defibrillator and biventricular device recipients: a novel ambulatory parameter to optimize heart failure management.

    Goetze, S, Zhang, Y, An, Q, Averina, V, Lambiase, P, Schilling, R et al..

    J Interv Card Electrophysiol. 2015;43 (1):21-9.

    PubMed PMID:25863797. PubMed Central PMC4438200.

    doi: 10.1007/s10840-015-9983-6.
  60. Increased prothrombotic profile in the left atrial appendage of atrial fibrillation patients.

    Breitenstein, A, Glanzmann, M, Falk, V, Maisano, F, Stämpfli, SF, Holy, EW et al..

    Int. J. Cardiol. 2015;185 :250-5.

    PubMed PMID:25814212.

    doi: 10.1016/j.ijcard.2015.03.092.
  61. Response to letter regarding "Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis".

    Anselmino, M, Matta, M, D'Ascenzo, F, Bunch, TJ, Schilling, RJ, Hunter, RJ et al..

    Circ Arrhythm Electrophysiol. 2015;8 (1):246.

    PubMed PMID:25691564.

    doi: 10.1161/CIRCEP.115.002697.
  62. A highly effective technique for transseptal endocardial left ventricular lead placement for delivery of cardiac resynchronization therapy.

    Domenichini, G, Diab, I, Campbell, NG, Dhinoja, M, Hunter, RJ, Sporton, S et al..

    Heart Rhythm. 2015;12 (5):943-9.

    PubMed PMID:25638701.

    doi: 10.1016/j.hrthm.2015.01.038.
  63. Relationship between contact force sensing technology and medium-term outcome of atrial fibrillation ablation: a multicenter study of 600 patients.

    Jarman, JWE, Panikker, S, DAS, M, Wynn, GJ, Ullah, W, Kontogeorgis, A et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (4):378-384.

    PubMed PMID:25546580.

    doi: 10.1111/jce.12606.
  64. RE-CIRCUIT study-randomized evaluation of Dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy.

    Calkins, H, Gerstenfeld, EP, Schilling, R, Verma, A, Willems, S, RE-CIRCUIT Study Steering Committee et al..

    Am. J. Cardiol. 2015;115 (1):154-5.

    PubMed PMID:25456859.

    doi: 10.1016/j.amjcard.2014.10.002.
  65. Rhythm Management of the Atrial Fibrillation Patient: Practical Implementation of the 2012 ESC Guidelines.

    Mountfort, K, Kuck, KH, Schilling, R.

    Eur Cardiol. 2014;9 (2):120-122.

    PubMed PMID:30310498. PubMed Central PMC6159397.

    doi: 10.15420/ecr.2014.9.2.120.
  66. Defining disease phenotypes using national linked electronic health records: a case study of atrial fibrillation.

    Morley, KI, Wallace, J, Denaxas, SC, Hunter, RJ, Patel, RS, Perel, P et al..

    PLoS ONE. 2014;9 (11):e110900.

    PubMed PMID:25369203. PubMed Central PMC4219705.

    doi: 10.1371/journal.pone.0110900.
  67. Impact of steerable sheaths on contact forces and reconnection sites in ablation for persistent atrial fibrillation.

    Ullah, W, Hunter, RJ, McLean, A, Dhinoja, M, Earley, MJ, Sporton, S et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (3):266-73.

    PubMed PMID:25346514.

    doi: 10.1111/jce.12573.
  68. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis.

    Anselmino, M, Matta, M, D'Ascenzo, F, Bunch, TJ, Schilling, RJ, Hunter, RJ et al..

    Circ Arrhythm Electrophysiol. 2014;7 (6):1011-8.

    PubMed PMID:25262686.

    doi: 10.1161/CIRCEP.114.001938.
  69. Comparison of robotic and manual persistent AF ablation using catheter contact force sensing: an international multicenter registry study.

    Ullah, W, Hunter, RJ, Haldar, S, McLean, A, Dhinoja, M, Sporton, S et al..

    Pacing Clin Electrophysiol. 2014;37 (11):1427-35.

    PubMed PMID:25220575.

    doi: 10.1111/pace.12501.
  70. Factors affecting catheter contact in the human left atrium and their impact on ablation efficacy.

    Ullah, W, Hunter, RJ, Baker, V, Dhinoja, MB, Sporton, S, Earley, MJ et al..

    J. Cardiovasc. Electrophysiol. 2015;26 (2):129-36.

    PubMed PMID:25213917.

    doi: 10.1111/jce.12542.
  71. Use of avatar virtual conferencing to co-ordinate cardiac multi-centre research.

    Haywood, GA, Davies, EJ, Boulos, MN, Rapanotti, L, Schilling, R, Todd, D et al..

    Int. J. Cardiol. 2014;176 (3):1086-8.

    PubMed PMID:25150495.

    doi: 10.1016/j.ijcard.2014.07.125.
  72. Does modification to the approach to contacting potential participants improve recruitment to clinical trials?.

    Sawhney, V, Graham, A, Campbell, N, Schilling, R.

    J Clin Med Res. 2014;6 (5):384-7.

    PubMed PMID:25110544. PubMed Central PMC4125335.

    doi: 10.14740/jocmr1879w.
  73. Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe.

    De Caterina, R, Ammentorp, B, Darius, H, Le Heuzey, JY, Renda, G, Schilling, RJ et al..

    Heart. 2014;100 (20):1625-35.

    PubMed PMID:25106421.

    doi: 10.1136/heartjnl-2014-305486.
  74. Predictors of new onset atrial fibrillation in patients with heart failure.

    Campbell, NG, Cantor, EJ, Sawhney, V, Duncan, ER, DeMartini, C, Baker, V et al..

    Int. J. Cardiol. 2014;175 (2):328-32.

    PubMed PMID:24985070.

    doi: 10.1016/j.ijcard.2014.05.023.
  75. Randomized trial comparing robotic to manual ablation for atrial fibrillation.

    Ullah, W, McLean, A, Hunter, RJ, Baker, V, Richmond, L, Cantor, EJ et al..

    Heart Rhythm. 2014;11 (11):1862-9.

    PubMed PMID:24960268.

    doi: 10.1016/j.hrthm.2014.06.026.
  76. The management of atrial fibrillation: summary of updated NICE guidance.

    Jones, C, Pollit, V, Fitzmaurice, D, Cowan, C, Guideline Development Group.

    BMJ. 2014;348 :g3655.

    PubMed PMID:24948694.

    doi: 10.1136/bmj.g3655.
  77. Robotics in invasive cardiac electrophysiology.

    Shurrab, M, Schilling, R, Gang, E, Khan, EM, Crystal, E.

    Expert Rev Med Devices. 2014;11 (4):375-81.

    PubMed PMID:24793740.

    doi: 10.1586/17434440.2014.916207.
  78. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures.

    Heidbuchel, H, Wittkampf, FH, Vano, E, Ernst, S, Schilling, R, Picano, E et al..

    Europace. 2014;16 (7):946-64.

    PubMed PMID:24792380.

    doi: 10.1093/europace/eut409.
  79. Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.

    Robson, J, Dostal, I, Mathur, R, Sohanpal, R, Hull, S, Antoniou, S et al..

    Br J Gen Pract. 2014;64 (622):e275-81.

    PubMed PMID:24771841. PubMed Central PMC4001131.

    doi: 10.3399/bjgp14X679705.
  80. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry.

    Le Heuzey, JY, Ammentorp, B, Darius, H, De Caterina, R, Schilling, RJ, Schmitt, J et al..

    Thromb. Haemost. 2014;111 (5):833-41.

    PubMed PMID:24651882.

    doi: 10.1160/TH13-12-1007.
  81. Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin.

    Page, SP, Herring, N, Hunter, RJ, Withycombe, E, Lovell, M, Wali, G et al..

    J. Cardiovasc. Electrophysiol. 2014;25 (6):585-90.

    PubMed PMID:24641450.

    doi: 10.1111/jce.12411.
  82. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].

    De Caterina, R, Renda, G, Sangiuolo, R, Attena, E, Di Lecce, L, Romeo, F et al..

    G Ital Cardiol (Rome). 2014;15 (2):99-109.

    PubMed PMID:24625849.

    doi: 10.1714/1424.15779.
  83. Target indices for clinical ablation in atrial fibrillation: insights from contact force, electrogram, and biophysical parameter analysis.

    Ullah, W, Hunter, RJ, Baker, V, Dhinoja, MB, Sporton, S, Earley, MJ et al..

    Circ Arrhythm Electrophysiol. 2014;7 (1):63-8.

    PubMed PMID:24443504.

    doi: 10.1161/CIRCEP.113.001137.
  84. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).

    Hunter, RJ, Berriman, TJ, Diab, I, Kamdar, R, Richmond, L, Baker, V et al..

    Circ Arrhythm Electrophysiol. 2014;7 (1):31-8.

    PubMed PMID:24382410.

    doi: 10.1161/CIRCEP.113.000806.
  85. The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE).

    Mielewczik, M, Cole, GD, Nowbar, AN, Schilling, R, Whinnett, ZI, Bordachar, P et al..

    J. Am. Coll. Cardiol. 2013;62 (25):2453.

    PubMed PMID:24355589.

    doi: 10.1016/j.jacc.2013.09.013.
  86. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF).

    Kirchhof, P, Ammentorp, B, Darius, H, De Caterina, R, Le Heuzey, JY, Schilling, RJ et al..

    Europace. 2014;16 (1):6-14.

    PubMed PMID:24084680. PubMed Central PMC3864758.

    doi: 10.1093/europace/eut263.
  87. Effect of atrial fibrillation ablation on myocardial function: insights from cardiac magnetic resonance feature tracking analysis.

    Ceelen, F, Hunter, RJ, Boubertakh, R, Sommer, WH, Armbruster, M, Schilling, RJ et al..

    Int J Cardiovasc Imaging. 2013;29 (8):1807-17.

    PubMed PMID:24002783.

    doi: 10.1007/s10554-013-0287-6.
  88. Utility of mapping signals to improve precision of atrioventricular node ablation.

    Yeo, WT, Sporton, SC, Dhinoja, M, Schilling, RJ, Earley, MJ.

    Pacing Clin Electrophysiol. 2013;36 (11):1357-63.

    PubMed PMID:23763518.

    doi: 10.1111/pace.12199.
  89. Are patients admitted to emergency departments with regular supraventricular tachycardia (SVT) treated appropriately?.

    Sawhney, V, Corden, B, Abdul-Mukith, K, Harris, T, Schilling, RJ.

    Clin Med (Lond). 2013;13 (2):146-8.

    PubMed PMID:23681861.

    doi: 10.7861/clinmedicine.13-2-146.
  90. Three-dimensional localization versus fluoroscopically only guided ablations: a meta-analysis.

    Shurrab, M, Laish-Farkash, A, Lashevsky, I, Morriello, F, Singh, SM, Schilling, RJ et al..

    Scand. Cardiovasc. J. 2013;47 (4):200-9.

    PubMed PMID:23647246.

    doi: 10.3109/14017431.2013.797099.
  91. The Prevalence of Low Left Atrial Appendage Emptying Velocity and Thrombus in Patients Undergoing Catheter Ablation for Atrial Fibrillation on Uninterrupted Peri-procedural Warfarin Therapy.

    Herring, N, Page, SP, Ahmed, M, Burg, MR, Hunter, RJ, Earley, MJ et al..

    J Atr Fibrillation. ;5 (6):761.

    PubMed PMID:28496828. PubMed Central PMC5153174.

    doi: 10.4022/jafib.761.
  92. Current genomics in cardiovascular medicine.

    Sawhney, V, Brouilette, S, Abrams, D, Schilling, R, O'Brien, B.

    Curr. Genomics. 2012;13 (6):446-62.

    PubMed PMID:23450299. PubMed Central PMC3426779.

    doi: 10.2174/138920212802510484.
  93. Impact of controlling atrial fibrillation on outcomes relevant to the patient: focus on dronedarone.

    Chahal, CA, Ali, O, Hunter, RJ, Schilling, RJ.

    Patient Relat Outcome Meas. 2012;3 :95-103.

    PubMed PMID:23378791. PubMed Central PMC3557702.

    doi: 10.2147/PROM.S16678.
  94. Diagnostic accuracy of cardiac magnetic resonance imaging in the detection and characterization of left atrial catheter ablation lesions: a multicenter experience.

    Hunter, RJ, Jones, DA, Boubertakh, R, Malcolme-Lawes, LC, Kanagaratnam, P, Juli, CF et al..

    J. Cardiovasc. Electrophysiol. 2013;24 (4):396-403.

    PubMed PMID:23293924.

    doi: 10.1111/jce.12063.
  95. Epicardial catheter ablation for ventricular tachycardia in heparinized patients.

    Page, SP, Duncan, ER, Thomas, G, Ginks, MR, Earley, MJ, Sporton, SC et al..

    Europace. 2013;15 (2):284-9.

    PubMed PMID:23002196.

    doi: 10.1093/europace/eus258.
  96. Seek referral to a heart rhythm specialist for atrial fibrillation.

    Schilling, RJ, Camm, J, Lip, G, Grace, A, Fay, M, Fitzpatrick, A et al..

    BMJ. 2012;344 :e4318.

    PubMed PMID:22734100.

    doi: 10.1136/bmj.e4318.
  97. Improved electrogram attenuation during ablation of paroxysmal atrial fibrillation with the Hansen robotic system.

    Duncan, ER, Finlay, M, Page, SP, Hunter, R, Goromonzi, F, Richmond, L et al..

    Pacing Clin Electrophysiol. 2012;35 (6):730-8.

    PubMed PMID:22494451.

    doi: 10.1111/j.1540-8159.2012.03381.x.
  98. Left atrial wall stress distribution and its relationship to electrophysiologic remodeling in persistent atrial fibrillation.

    Hunter, RJ, Liu, Y, Lu, Y, Wang, W, Schilling, RJ.

    Circ Arrhythm Electrophysiol. 2012;5 (2):351-60.

    PubMed PMID:22294615.

    doi: 10.1161/CIRCEP.111.965541.
  99. A randomised comparison of Cartomerge vs. NavX fusion in the catheter ablation of atrial fibrillation: the CAVERN Trial.

    Finlay, MC, Hunter, RJ, Baker, V, Richmond, L, Goromonzi, F, Thomas, G et al..

    J Interv Card Electrophysiol. 2012;33 (2):161-9.

    PubMed PMID:22119854. PubMed Central PMC3305875.

    doi: 10.1007/s10840-011-9632-7.
  100. First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead.

    Sperzel, J, Dänschel, W, Gutleben, KJ, Kranig, W, Mortensen, P, Connelly, D et al..

    Europace. 2012;14 (3):365-72.

    PubMed PMID:21993431.

    doi: 10.1093/europace/eur322.
Search PubMed